Start-Up Spotlight: Peripal, Easing Peritoneal Dialysis For ESRD

 
• By Jenny Blair

Peritoneal dialysis (PD) can allow renal patients to dialyze at home, but connecting one’s catheter to the equipment carries an infection risk and is too tricky for some patients. Swiss startup Peripal AG, which closed a Series A1 round with prominent Swiss investors in July, is betting that its patient-aid device will make PD easier and safer while cutting costs for medical systems.

Start-up Spotlight

Peritoneal dialysis (PD) offers many end-stage renal disease (ESRD) patients a way to take their renal replacement therapy into their own hands at home, liberating them from lengthy sessions hooked to machines at hemodialysis centers. But connecting oneself to the dialysis equipment can be difficult and risky. Zürich-based startup Peripal AG has developed a connector it hopes will eliminate that barrier to PD — and potentially boost a niche market for home dialysis care.

“Home care is such an important trend in the entire health care industry. We will be on the top of that wave,” says CEO Sandra Neumann. “We hope that we...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Startups & SMEs

More from Business